ArticlePloS one2020
Changes in the secondary compounds of persimmon leaves as a defense against circular leaf spot caused by Plurivorosphaerella nawae.
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 12 citations in OpenAlex.
- Effects of household washing methods and post-ripening on the residue dissipation of the systemic fungicides mandestrobin and metconazole in Persimmons.Scientific reports · 2026Article
- Persimmon Leaves: Nutritional, Pharmaceutical, and Industrial Potential-A Review.Plants (Basel, Switzerland) · 2023Review
- Cytogenetic Characterization and Metabolomic Differences of Full-Sib Progenies ofPlants (Basel, Switzerland) · 2023Article
- Importance of Insoluble-Bound Phenolics to the Antioxidant Potential Is Dictated by Source Material.Antioxidants (Basel, Switzerland) · 2023Review
- Phenolic Compounds and Antioxidant Capacity of Sea Cucumber (Antioxidants (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circular leaf spot, caused by the ascomycetous fungus Plurivorosphaerella nawae (= Mycosphaerella nawae), is the most problematic fungal disease of persimmon worldwide. In Korea, persimmon exposed to P. nawae inoculum (ascospores) from May to August shows visible circular leaf spot disease symptoms from the end of August to early September. It is important to identify factors affecting this long latent period. The objective of this study was to elucidate the relation between the development of symptom of circular leaf spot and the content of phenolics compounds and vitamin C as well as the antioxidant activities in leaves. Healthy leaves (both young and old) and infected leaves of circular leaf spot-susceptible persimmon cultivar were harvested in 2016. The content of phenolics (total phenols, flavonoids, and tannins) and vitamin C, and their antioxidant activities were analyzed in all types of leaves. Compared with the asymptomatic leaves (old) and the asymptomatic parts of the infected leaves, the symptomatic parts of the infected leaves, symptomatic leaves, and asymptomatic young leaves showed significantly higher content of phenolics and vitamin C, and higher antioxidant activities. Disease incidence and severity were estimated for older leaves (emerged in early May) and younger leaves (emerged at the end of June) in 2017 and 2018. The AUDPC was higher in old leaves than younger leaves. The disease progression was much faster and severe in the older than in the younger leaves. Similar results were found in field experiments. Higher content of phenolics and antioxidant activities in the younger leaves may contribute to circular leaf spot resistance in persimmon. Furthermore, accumulation of phenolics and antioxidant activity in the infected leaves is a post-infection response and the first stage of the defense mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.